Rep. April McClain Delaney Purchases Shares of BWX Technologies, Inc. (NYSE:BWXT)

Posted by Stanley Muller on Aug 5th, 2026

Representative April McClain Delaney (Democratic-Maryland) recently bought shares of BWX Technologies, Inc. (NYSE:BWXT). In a filing disclosed on August 03rd, the Representative disclosed that they had bought between $15,001 and $50,000 in BWX Technologies stock on July 24th.

Representative April McClain Delaney also recently made the following trade(s):

Purchased $15,001 – $50,000 in shares of Life Time Group (NYSE:LTH) on 7/31/2026.
Purchased $15,001 – $50,000 in shares of Liberty Media Corporation – Liberty Formula One Series C (NASDAQ:FWONK) on 7/31/2026.
Sold $1,001 – $15,000 in shares of Corpay (NYSE:CPAY) on 7/31/2026.
Purchased $15,001 – $50,000 in shares of C.H. Robinson Worldwide (NASDAQ:CHRW) on 7/31/2026.
Sold $1,001 – $15,000 in shares of STERIS (NYSE:STE) on 7/31/2026.
Purchased $15,001 – $50,000 in shares of Somnigroup International (NYSE:SGI) on 7/30/2026.
Purchased $1,001 – $15,000 in shares of Entegris (NASDAQ:ENTG) on 7/30/2026.
Sold $1,001 – $15,000 in shares of Corpay (NYSE:CPAY) on 7/30/2026.
Purchased $1,001 – $15,000 in shares of Life Time Group (NYSE:LTH) on 7/30/2026.
Sold $1,001 – $15,000 in shares of Service Corporation International (NYSE:SCI) on 7/30/2026.

BWX Technologies Stock Down 1.0%

Shares of BWX Technologies stock traded down $1.70 during trading on Wednesday, hitting $170.70. 164,891 shares of the stock traded hands, compared to its average volume of 1,016,150. The company has a current ratio of 2.40, a quick ratio of 2.33 and a debt-to-equity ratio of 1.58. The stock’s fifty day simple moving average is $186.82 and its 200 day simple moving average is $201.30. The firm has a market cap of $15.64 billion, a P/E ratio of 45.64, a price-to-earnings-growth ratio of 2.96 and a beta of 0.76. BWX Technologies, Inc. has a 52-week low of $157.10 and a 52-week high of $241.82.

BWX Technologies (NYSE:BWXT – Get Free Report) last issued its earnings results on Monday, August 3rd. The technology company reported $1.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.04 by $0.03. The company had revenue of $901.62 million for the quarter, compared to analysts’ expectations of $902.41 million. BWX Technologies had a net margin of 10.11% and a return on equity of 31.34%. The firm’s quarterly revenue was up 18.0% on a year-over-year basis. During the same period in the prior year, the business earned $1.02 EPS. BWX Technologies has set its FY 2026 guidance at 4.700-4.800 EPS. On average, equities analysts predict that BWX Technologies, Inc. will post 4.61 earnings per share for the current fiscal year.

BWX Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, September 4th. Stockholders of record on Tuesday, August 18th will be given a dividend of $0.27 per share. The ex-dividend date of this dividend is Tuesday, August 18th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.6%. BWX Technologies’s dividend payout ratio is presently 28.88%.

Analysts Set New Price Targets

A number of analysts have weighed in on BWXT shares. Weiss Ratings lowered BWX Technologies from a “buy (b-)” rating to a “hold (c+)” rating in a report on Wednesday, July 29th. Wall Street Zen raised shares of BWX Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. BTIG Research reissued a “buy” rating and set a $235.00 target price on shares of BWX Technologies in a research report on Tuesday. Zacks Research lowered shares of BWX Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, May 11th. Finally, Deutsche Bank Aktiengesellschaft upgraded BWX Technologies from a “hold” rating to a “buy” rating and increased their price objective for the company from $205.00 to $255.00 in a report on Friday, May 15th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, BWX Technologies currently has an average rating of “Moderate Buy” and an average price target of $228.20.

View Our Latest Stock Analysis on BWXT

More BWX Technologies News

Here are the key news stories impacting BWX Technologies this week:

Positive Sentiment: Strong quarterly results: BWXT reported second-quarter EPS of $1.07, exceeding the $1.04 analyst consensus, while revenue rose 18% year over year to approximately $901.6 million. Commercial operations revenue increased 72% to $302.5 million. BWX Technologies Reports Second Quarter 2026 Results
Positive Sentiment: Higher 2026 outlook and cash flow: Management raised full-year 2026 adjusted EPS guidance to $4.70-$4.80 and free cash flow guidance to $345 million-$360 million. The company cited strong execution, operating performance and growing nuclear demand. BWXT targets higher EPS and free cash flow outlook
Positive Sentiment: Strategic medical-business sale: BWXT agreed to sell its medical business to Nordic Capital in a transaction valued at up to $800 million, while retaining a minority stake. Proceeds should provide capital for commercial nuclear, small modular reactor and defense-related expansion, sharpening BWXT’s focus on nuclear markets. BWXT Selling Medical Business to Nordic Capital
Positive Sentiment: Supportive analyst view: BTIG reaffirmed its Buy rating and $235 price target. Northland Securities raised its FY2026 EPS forecast to $4.71 from $4.68 and FY2027 to $5.17 from $5.11, above the current-year consensus estimate of $4.61.
Neutral Sentiment: BWXT maintained its quarterly dividend at $0.27 per share, payable September 4 to shareholders of record August 18. The dividend offers a modest yield of approximately 0.6%.
Negative Sentiment: Northland lowered its Q3 2026 EPS estimate to $1.18 from $1.22, suggesting some softness in the next quarter despite higher full-year and 2027 projections. BWXT also trades at a relatively elevated earnings multiple, which may increase sensitivity to execution or broader market rotation.

Insider Activity

In other BWX Technologies news, CFO Michael Thomas Fitzgerald sold 2,417 shares of BWX Technologies stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $209.25, for a total transaction of $505,757.25. Following the transaction, the chief financial officer directly owned 6,884 shares of the company’s stock, valued at $1,440,477. The trade was a 25.99% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Rex D. Geveden sold 10,000 shares of BWX Technologies stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $204.81, for a total transaction of $2,048,100.00. Following the transaction, the chief executive officer owned 202,491 shares in the company, valued at $41,472,181.71. The trade was a 4.71% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company’s stock.

Hedge Funds Weigh In On BWX Technologies

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Cannell & Spears LLC increased its holdings in BWX Technologies by 4.0% in the first quarter. Cannell & Spears LLC now owns 1,312 shares of the technology company’s stock valued at $251,000 after buying an additional 50 shares in the last quarter. Wedbush Securities Inc. lifted its holdings in shares of BWX Technologies by 4.3% in the fourth quarter. Wedbush Securities Inc. now owns 1,263 shares of the technology company’s stock valued at $218,000 after purchasing an additional 52 shares in the last quarter. Oppenheimer Asset Management Inc. grew its position in shares of BWX Technologies by 1.0% in the fourth quarter. Oppenheimer Asset Management Inc. now owns 5,448 shares of the technology company’s stock valued at $942,000 after purchasing an additional 54 shares during the last quarter. Guggenheim Capital LLC lifted its stake in BWX Technologies by 2.2% in the 4th quarter. Guggenheim Capital LLC now owns 2,598 shares of the technology company’s stock valued at $449,000 after buying an additional 55 shares in the last quarter. Finally, Stratos Wealth Partners LTD. increased its position in BWX Technologies by 3.5% during the fourth quarter. Stratos Wealth Partners LTD. now owns 1,979 shares of the technology company’s stock worth $342,000 after buying an additional 67 shares in the last quarter. Hedge funds and other institutional investors own 94.39% of the company’s stock.

About Representative McClain Delaney

April McClain-Delaney (Democratic Party) is a member of the U.S. House, representing Maryland’s 6th Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

McClain-Delaney (Democratic Party) is running for re-election to the U.S. House to represent Maryland’s 6th Congressional District. She declared candidacy for the 2026 election.

April McClain-Delaney grew up in Buhl, Idaho, where her father was a potato farmer. She obtained her bachelor’s degree in communications from Northwestern University in 1986 and her law degree from Georgetown Law Center in 1989. McClain-Delaney worked in communications law, first with the satellite firm Orion Network Systems and later as the Washington director for Common Sense Media, a nonprofit focused on technology and children. In 2022, McClain-Delaney joined the U.S. Department of Commerce under President Joe Biden (D) as deputy assistant secretary for communications and information. McClain-Delaney served on the board of the Georgetown University Law Center, the International Center for Research on Women, and the Northwestern University School of Communications.

About BWX Technologies

(Get Free Report)

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.